Globus Medical GMED FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Globus Medical's FX effect on cash?
- Globus Medical (GMED) reported FX effect on cash of -$3.09M in Q1 2026.
- How has Globus Medical's FX effect on cash changed year-over-year?
- Globus Medical's FX effect on cash decreased by 187.4% year-over-year, from $3.54M to -$3.09M.
- What is the long-term trend for Globus Medical's FX effect on cash?
- Over 2 years (2021 to 2025), Globus Medical's FX effect on cash has grown at a 414.5% compound annual growth rate (CAGR), from -$848K to $22.45M.
- What does FX effect on cash mean?
- The gain or loss in cash value caused by changes in foreign currency exchange rates.
- How do you interpret FX effect on cash?
- A positive value indicates a favorable currency movement increasing cash value, while a negative value indicates a loss due to currency depreciation.
- How does FX effect on cash compare across companies?
- Multinational medical device companies often report this as a minor adjustment unless there is significant global currency volatility.